Jamie Christensen - Dec 16, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Reena Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 16, 2022
Transactions value $
-$103,624
Form type
4
Date filed
12/20/2022, 03:02 PM
Previous filing
Dec 5, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$104K -2.41K -2.31% $43.00 102K Dec 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.